Cargando…
Proportional Upregulation of CD97 Isoforms in Glioblastoma and Glioblastoma-Derived Brain Tumor Initiating Cells
CD97 is a novel glioma antigen that confers an invasive phenotype and poor survival in patients with glioblastoma (GBM), the most aggressive primary malignant brain tumor. The short isoform of CD97, known as EGF(1,2,5), has been shown to promote invasion and metastasis, but its role in gliomas and G...
Autores principales: | Safaee, Michael, Fakurnejad, Shayan, Bloch, Orin, Clark, Aaron J., Ivan, Michael E., Sun, Matthew Z., Oh, Taemin, Phillips, Joanna J., Parsa, Andrew T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340952/ https://www.ncbi.nlm.nih.gov/pubmed/25714433 http://dx.doi.org/10.1371/journal.pone.0111532 |
Ejemplares similares
-
Immunocompetent murine models for the study of glioblastoma immunotherapy
por: Oh, Taemin, et al.
Publicado: (2014) -
Overexpression of CD97 Confers an Invasive Phenotype in Glioblastoma Cells and Is Associated with Decreased Survival of Glioblastoma Patients
por: Safaee, Michael, et al.
Publicado: (2013) -
Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma
por: Clark, Aaron J., et al.
Publicado: (2016) -
Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells
por: Clark, Aaron J, et al.
Publicado: (2014) -
Overexpression of Calcium-Permeable Glutamate Receptors in Glioblastoma Derived Brain Tumor Initiating Cells
por: Oh, Michael C., et al.
Publicado: (2012)